AI-assisted research analysis by FutureKnowledge. Sources checked 5 November 2026. This is not investment advice.
Reviewed by FutureKnowledge: figures, dates and attributions were checked against the linked sources before publication.
China has blocked SoftBank Group’s $5.4 billion purchase of ABB’s robotics business in China, ABB confirmed on 5 November, as SoftBank shares fell 6.8% in Tokyo and the wider deal was put in doubt.
The news was first reported by the Financial Times, which said China’s National Development and Reform Commission had told SoftBank it would not allow the purchase, according to investingLive and BusinessWorld. ABB later said it had been informed that China’s foreign investment security review office had prohibited the takeover of the China business, while ABB and SoftBank remain in constructive talks, Handelsblatt (via dpa-AFX) reported.
What happened to the SoftBank ABB robotics deal
ABB agreed in October 2025 to sell its Robotics division to SoftBank for an enterprise value of $5.375 billion, according to ABB’s announcement. The deal replaced ABB’s earlier plan to spin off the unit as a separately listed company. It was subject to regulatory approvals and expected to close in mid-to-late 2026.
The European Commission cleared the deal without conditions in March, while the US review had not finished, Minute Mirror reported. China was the last major hurdle, and SoftBank had expected approval until the week before, according to the same report.
ABB’s statement, as reported by FourWeekMBA, said the approval process was managed by SoftBank and that the two companies are working constructively on the transaction. ABB told Swiss news agency AWP it would not yet comment on what the decision means for the whole sale, Handelsblatt said. SoftBank declined to comment, according to ad-hoc-news.
Conflicting details
Reports differ on two points. On the authority, the FT-based reports name the NDRC, while ABB referred to the office that runs China’s foreign investment security review. On scope, ABB’s wording covers the China business, and it is not yet clear whether the rest of the deal can proceed without it; Handelsblatt described the entire deal as on the brink.
Why China blocked it
No official reason has been published. According to the FT, as reported by BusinessWorld and Handelsblatt, the concern was that data from robotics production in China could be moved abroad and used to train artificial intelligence models, possibly including those of OpenAI, in which SoftBank is a major investor. FutureKnowledge covered SoftBank-backed OpenAI’s latest $11 billion funding round at a $1.25 trillion valuation earlier this week.
China matters a great deal to this business. BusinessWorld said China accounts for about 30% of ABB’s robotics business, while investingLive described China as the unit’s largest market. ABB Robotics had 2024 revenue of $2.3 billion, about 7% of ABB group revenue, an operational EBITA margin of 12.1% and about 7,000 employees, according to ABB’s 2025 announcement.
Market reaction: SoftBank and ABB shares
SoftBank shares closed at ¥3,980 in Tokyo, down ¥289 or 6.77%, according to figures cited by FourWeekMBA. The fall was not only about ABB: investingLive noted a wider sell-off in AI stocks after the US midterm elections and a drop in Arm Holdings shares overnight, the same pressure seen in the KOSPI’s fall after the midterms. ABB shares opened about 2% lower in Zurich, FourWeekMBA reported.
How this affects businesses and India
For SoftBank, the decision is a setback to chairman Masayoshi Son’s push into “physical AI”, the use of AI in robots and machines. ABB Robotics was meant to give SoftBank manufacturing scale and industrial customers. Analyst Kirk Boodry, quoted by Minute Mirror, said the unit lacks cutting-edge innovation but brings manufacturing know-how that could turn robotic concepts into real businesses.
For ABB, the expected cash proceeds of about $5.3 billion and a book gain of about $2.4 billion, both set out in its 2025 announcement, are now uncertain. ABB had also said the robotics unit had limited business and technology synergies with the rest of the group, which suggests it will still look for a way to separate it.
For global dealmakers, the case shows that China’s review of foreign investment can stop a deal between two non-Chinese companies when the target has significant operations in China. This adds risk for large technology deals, including recent ones such as Marvell’s planned $115 billion purchase of Lumentum, where approvals in several countries are needed.
For India, there is no direct link in the reports. Indirectly, Indian manufacturers that buy industrial robots and multinationals considering where to place factories will watch how data and technology rules affect suppliers with large China operations.
Who is more or less exposed
- More exposed: foreign buyers of businesses with large operations or data in China, especially in AI, robotics and semiconductors.
- Exposed to uncertainty: sellers relying on deal proceeds, and employees of units waiting for approvals.
- Less exposed: deals where the target’s China operations are small or can easily be separated.
Scenarios to watch
These are conditional scenarios, not predictions.
| If this happens | Possible effect |
|---|---|
| SoftBank and ABB restructure the deal to exclude China | A smaller deal could close, with ABB keeping or separately selling the China business |
| SoftBank reapplies with data safeguards | A second review could take months and approval is not assured |
| The deal is abandoned | ABB would need a new plan for robotics, such as a revived separation or another buyer |
| Other foreign deals with China operations face similar reviews | Buyers may price in more regulatory risk or carve out China assets in advance |
What to watch next
- A formal update from ABB or SoftBank on the deal’s structure and timeline.
- Whether the US review is completed and on what terms.
- ABB’s next earnings update for any change to its robotics plans.
Bottom line
China’s decision has stopped, at least for now, the China part of SoftBank’s $5.4 billion ABB robotics deal, the business’s most important market. Both companies say they are still talking, but the path to closing is unclear, and the case highlights growing regulatory risk around AI-linked data and cross-border deals.
Method note: This analysis compared ABB’s October 2025 announcement of the sale (primary source) with reports from investingLive and BusinessWorld (both citing the Financial Times), Handelsblatt (dpa-AFX), Minute Mirror, ad-hoc-news and FourWeekMBA. ABB’s 5 November statement was not available to us directly and is described as reported. Differences on the Chinese authority involved and the scope of the block are noted above.